How This Is Building Me

How This Is Building Me
  • 5.0 (19)
  • SCIENCE
  • UPDATED MONTHLY

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. 

  1. How Reimagined Research Endeavors Intersect With Dignified End-of-Life Care: With D. Ross Camidge, MD, PhD; and Charles D. Blanke, MD, FACP, FASCO

    5D AGO

    How Reimagined Research Endeavors Intersect With Dignified End-of-Life Care: With D. Ross Camidge, MD, PhD; and Charles D. Blanke, MD, FACP, FASCO

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Charles D. Blanke, MD, FACP, FASCO, a professor of medicine in the School of Medicine at the Oregon Health & Science University (OHSU) Knight Cancer Institute in Portland. Drs Camidge and Blanke discuss Dr Blanke's unique career path from pioneering targeted cancer therapies to becoming a leading advocate for medical aid in dying. A Type 1 diabetes diagnosis directed Dr Blanke toward an interest in internal medicine and oncology. During his fellowship and early faculty days, he established a reputation for his hard work pursuing research opportunities, even when initial projects were unsuccessful. Blanke’s most transformative scientific achievement occurred at OHSU, where he spearheaded the use of Imatinib (Gleevec) for the management of gastrointestinal stromal tumor (GIST). By targeting the KIT mutation, this research turned a previously untreatable malignancy into one with a high response rate, marking a landmark moment for personalized oncology. Equally significant in Dr Blanke’s career is his role in medical aid in dying. Practicing in Oregon, the first state to legalize the option, he has written hundreds of prescriptions for patients with terminal diseases. Blanke views medical aid in dying as a vital extension of patient care. As the former chair of SWOG, Dr Blanke modernized clinical research by introducing term limits, increasing access to clinical trials among, and championing the development of pragmatic trials with broader patient eligibility criteria. Throughout his tenure, he emphasized the importance of patient advocacy and the altruistic nature of cooperative research. Having recently stepped down from his leadership at SWOG, he intends to focus his future efforts on patient rights and medical aid in dying advocacy.

    1h 12m
  2. How Surgical Determination Intersects With Human Connection: With D. Ross Camidge, MD, PhD; and Robert A Meguid, MD, MPH, FACS

    APR 29

    How Surgical Determination Intersects With Human Connection: With D. Ross Camidge, MD, PhD; and Robert A Meguid, MD, MPH, FACS

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Robert A Meguid, MD, MPH, FACS, a thoracic and cardiac surgeon, as well as a professor of cardiothoracic surgery, at the University of Colorado in Aurora. Drs Camidge and Meguid discussed Dr Meguid’s journey into medicine, which was heavily influenced by his parents, both of whom were academic physicians. A first-generation American, Dr Meguid grew up watching his father operate and working in his father's research lab, experiences that ignited a lifelong interest in the scientific method and patient care. Dr Meguid pursued a combined 8-year medical program before matching into a residency in general surgery. During his residency, he spent 3 years in research, earning a master’s degree in public health and shifting his focus toward surgical outcomes and risk analysis. After completing a cardiothoracic fellowship, he joined the University of Colorado, where he helped expand the thoracic surgery program and pioneered robotic-assisted techniques. A shift in Dr Meguid’s perspective occurred when he suffered a life-threatening medical event during a family vacation in Australia. He contracted fulminant septic shock resulting from human metapneumovirus and group A strep, leading to respiratory and renal failure. After being intubated for several weeks and losing significant muscle mass, he was life-flighted back to his own ICU in Denver to begin recovery. This experience as a patient, during which he had to relearn how to stand and move, deepened his empathy and reinforced his commitment to patient-centered care. Currently, Dr Meguid is a leader in his field, focusing on thoracic oncology and complex chest wall reconstructions, such as that of the adult pectus excavatum. He remains dedicated to academic research on surgical risk assessment, ensuring that patients are empowered to make informed decisions about their care.

    1h 7m
  3. How Strategic Partnerships Expand the Reach of Cancer Research: With D. Ross Camidge, MD, PhD; and Dajan O'Donnell, PhD

    APR 15

    How Strategic Partnerships Expand the Reach of Cancer Research: With D. Ross Camidge, MD, PhD; and Dajan O'Donnell, PhD

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Camidge sat down with Dajan O'Donnell, PhD, who is the director of Research Partnerships at Cancer Research Society in Montreal, Canada. Camidge and O'Donnell discussed O’Donnell’s journey into science. After being steered away from a career in science during grade school but re-igniting his interest in the field as a young adult, O'Donnell earned a PhD in neurology and neurosurgery and then worked for AstraZeneca, where he helped build a Montreal-based research unit from scratch that specialized in identifying novel targets for chronic pain. O’Donnell’s transition to the nonprofit sector was sparked by the closure of AstraZeneca’s Montreal site and a personal diagnosis of a desmoid tumor that required multiple aggressive surgeries, an experience that fueled his passion for supporting research that directly affects patients. Before joining Cancer Research Society, O'Donnell worked for Exactis Innovation, where he navigated complex provincial health care barriers to create a national molecular registry for patients with cancer. Since joining Cancer Research Society, O’Donnell has expanded the organization's reach. Despite its relatively small size, Cancer Research Society is highly efficient, focusing almost entirely on funding research across all cancer types. Under O'Donnell's leadership, the organization’s financial commitment to cancer research has increased. Currently, O’Donnell is spearheading an unprecedented initiative to support investigator-initiated clinical trials in Canada. By leveraging partnerships with other agencies and foundations, this project aims to enhance clinical trial capacity across the country. This initiative serves as a cornerstone of O'Donnell's legacy as he prepares to transition into an advisory role over the next few years.

    58 min
  4. How a Passion for Justice Leads the Fight in Tobacco Litigation: With D. Ross Camidge, MD, PhD; and Alex Alvarez

    APR 1

    How a Passion for Justice Leads the Fight in Tobacco Litigation: With D. Ross Camidge, MD, PhD; and Alex Alvarez

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Alex Alvarez, a board-certified civil trial lawyer who specializes in tobacco litigation and jury selection. Camidge and Alvarez discussed Alvarez's career path, which he attributes to a deep-seated passion for upholding justice. Alvarez’s professional life began early, when he became one of the youngest police officers in Miami. After working in patrol during a period of significant civil unrest, he moved into the detective bureau, eventually joining the homicide division. There, he worked on high-profile investigations. During a federal trial for corrupt officers, Alvarez served as the lead investigator and sat at the counsel table, an experience that inspired him to become a trial lawyer. Although Alvarez initially planned to be a prosecutor, a prominent trial lawyer convinced him to enter private practice, focusing on high-end products liability and medical negligence. Alvarez eventually founded his own firm and became a leading figure in tobacco litigation. His cases focus on corporate malfeasance, arguing that tobacco companies engineered cigarettes to be addictive. He also sues for fraud, citing the industry’s history of denying the health risks associated with cigarettes and the marketing flaws surrounding "safer" cigrette alternatives. A master of jury selection, Alvarez has tried several tobacco cases. He emphasized the importance of finding jurisdictions where jurors are less likely to blame the smoker and more likely to hold corporations accountable. Alvarez's law firm is a family-run business involving his children and relatives. Today, Alvarez is shifting toward consulting and mentoring the next generation of lawyers to continue the fight against tobacco.

    1h 7m
  5. How a Devotion to Heath Care Conquered Societal Barriers: With D. Ross Camidge, MD, PhD; and Khari Reed, MHSA, FACHE

    MAR 18

    How a Devotion to Heath Care Conquered Societal Barriers: With D. Ross Camidge, MD, PhD; and Khari Reed, MHSA, FACHE

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences.  In this episode, Dr Camidge sat down with Khari Reed, MHSA, FACHE. Dr Reed is the vice president of Oncology Services at HonorHealth in Scottsdale, Arizona. Drs Reed and Camidge dug into what sparked Dr Reed’s illustrious health care career. Dr Reed’s journey began on the south side of Chicago, where he was raised in the neighborhood of Chatham. Influenced by his parents’ investment in community building, he grew up with a commitment to education and giving back to those around him. Dr Reed pointed out how his affinity for health care came from his early time spent in the hospital due to childhood asthma, which caused him to develop an appreciation for the physicians and health care workers that helped him feel better. Dr Reed’s career journey is exemplary of a commitment to clinical excellence, operational resilience, and diverse experiences. From his beginnings at the University of Michigan in Ann Arbor to a years-long career wearing many hats for The John Hopkins Hospital in Baltimore, Maryland, to now leading cancer care at Honor Health, Dr Reed has earned his stripes as a decorated and versatile health care professional. Overcoming unfavorably stacked odds has been a common theme woven throughout every stop of Dr Reed’s career. At the Loyola University Medical Center in Chicago, Illinois, Dr Reed led the oncology service line through the COVID-19 pandemic, establishing an incident command center that kept ambulatory cancer care operational when other departments closed. Moreover, Dr Reed navigated institutional barriers by completing a rigorous self-designed career plan, mastering complex financial systems, volunteering to gain practical experience, and breaking racial stigmas in health care. Now at HonorHealth, Dr Reed continues to treat patients like family and eyes future career advancements at the hospital, focused on creating self-sustaining organizations that prioritize high-quality oncology care.

    1h 15m
  6. How an Interest in Scientific Intricacies Evolved to Transform the Biotechnology Field: With D. Ross Camidge, MD, PhD; and Tim Clackson, PhD

    MAR 4

    How an Interest in Scientific Intricacies Evolved to Transform the Biotechnology Field: With D. Ross Camidge, MD, PhD; and Tim Clackson, PhD

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Tim Clackson, PhD. Dr Clackson is a biotechnology executive, and was most recently chief executive officer of IDRx.  Drs Camidge and Clackson discussed Dr Clackson’s career journey through the biotechnology field, which began when his innate curiosity about biology and evolution led him to study biochemistry. He then pursued his PhD and was part of the small team that developed antibody phage display libraries, a breakthrough technology that allows scientists to mimic the immune system in a test tube to find specific antibodies. This work was foundational to the discovery of major drugs and contributed to the awarding of a Nobel Prize in 2018. In 1991, Dr Clackson moved to the US to pursue a postdoc at Genentech, where he was inspired by the company's vibrant and optimistic research environment. He then joined Ariad Pharmaceuticals, where he stayed for more than 20 years, evolving from a bench scientist to president of R&D. A major highlight of his tenure was the development of ponatinib (Iclusig) for the treatment of patients with chronic myeloid leukemia. He also navigated significant challenges, including ponatinib's temporary market withdrawal due to safety concerns, which the company eventually resolved by narrowing the drug's clinical application. In the following years, Dr Clackson transitioned into chief executive officer roles at other biotech firms, such as IDRx. He noted that although acquisitions often result in leadership changes—humorously stating, "the higher you are, the quicker you go"—he enjoyed the storytelling aspect of pitching scientific strategies to investors. In the present day, Dr Clackson remains active in the biotechnology industry through board service and entrepreneurship.

    1h 5m
  7. How Patient Prioritization Paved the Way for a Legacy of Oncology Care: With D. Ross Camidge, MD, PhD; and Robert Kantor, MD

    FEB 18

    How Patient Prioritization Paved the Way for a Legacy of Oncology Care: With D. Ross Camidge, MD, PhD; and Robert Kantor, MD

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. In this episode, Dr Camidge sat down with Robert Kantor, MD. Dr Kantor is associate medical director of Medical Oncology & Hematology at Private Health Management. Drs Camidge and Kantor reflected on Dr Kantor's decades-long career. Inspired by his father’s devotion to patients, Dr Kantor fast-tracked his education, entering medical school at Wayne State University without completing an undergraduate degree. Following fellowship, he intentionally chose private practice over academic oncology to focus on direct patient care and making a difference in the lives of patients' families. Dr Kantor’s career illustrates the shifting landscape of American medicine. He has navigated various oncology practice models, including a corporate merger that he felt compromised patient care. In 2008, he took the risk of launching his own solo practice, successfully bringing trusted staff and a dedicated patient base with him. Dr Kantor eventually retired from clinical practice due to burnout, which was exacerbated by corporate management challenges and the inefficiencies of electronic medical records. His retirement evolved into an "encore career" as an associate medical director for Private Health Management. In this consultative role, he provides clinical oversight for complex oncology cases, helping patients navigate toward personalized cancer vaccines, clinical trials, and cutting-edge therapies. Dr Kantor expressed that this work has brought him renewed enthusiasm for the field of oncology, as it allows him to use his decades of experience with a basis of a better work-life balance. He remains passionate about how these high-end, personalized technologies will eventually make their way into routine clinical practice to benefit the broader patient population.

    1h 16m
  8. How Physics, Medicine, and Lived Experience Shaped a Career in Breast Cancer Research and Risk Evaluation: With Ross Camidge, MD; and Sofia Diana Merajver, MD, PhD

    FEB 4

    How Physics, Medicine, and Lived Experience Shaped a Career in Breast Cancer Research and Risk Evaluation: With Ross Camidge, MD; and Sofia Diana Merajver, MD, PhD

    How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences.In this episode, Dr Camidge sat down with Sofia Diana Merajver, MD, PhD, a physician-scientist whose career bridges physics, medicine, and population health. Dr Merajver is the scientific director of the Breast Cancer Program, director of the Breast and Ovarian Cancer Risk Evaluation Program, and a professor of internal medicine and epidemiology at the University of Michigan Rogel Cancer Center in Ann Arbor. In this discussion, she reflected on a lifelong journey shaped by immigration, intellectual curiosity, and a commitment to science in service of human health.  

    59 min
See All (59)

5
out of 5
19 Ratings

About

World-renowned oncologist D. Ross Camidge, MD, PhD, sits down with guests to discuss the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences. 

Information

You Might Also Like